Review



smartarray microarray chips capitalbio beijing china  (CapitalBio Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    CapitalBio Corporation smartarray microarray chips capitalbio beijing china
    <t>Microarray</t> analysis uncovered an altered and specific transcriptional profile underlying the cell shape change and the suppression of the metastatic potential by Runx3. ( A ) Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations assigned different repertoires of differentially expressed genes (DEGs) that were regulated by Runx3 in B16-F10 cells and, in the case of B16-F0 cells vs. B16-F10 cells, to the terms relevant to the actin cytoskeleton and adhesion. Each GO/KEGG annotation term is inscribed as a caption. The number of DEGs within a repertoire is described at x axis. The columns for the downregulated and the upregulated DEGs are shown in different colors as explained at the top of the figure., Down/Up by Runx3 indicates the appearance of DEGs in the case of B16-F10/Runx3 cells vs. mock control B16-F10 cells. Down/Up in B16-F0 indicates the appearance of DEGs in the case of B16-F0 cells vs. B16-F10 cells. Down/Up in common indicates the appearance of same DEGs in both cases. ( B ) Runx3 upregulated the expression of extracellular matrix (ECM) genes. The summary table indicates the gene names and their corresponding fold changes. ( C ) Runx3 regulated the expression of a list of DEGs that were inversely associated with an increase in the metastatic potential of B16-F10 cells compared to B16-F0 cells. The heatmap shows the gene names and their fold changes in the cases of B16-F10/Runx3 cells vs. mock control B16-F10 cells and B16-F0 cells vs. B16-F10 cells, respectively.
    Smartarray Microarray Chips Capitalbio Beijing China, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/smartarray+tm+microarray+system/pmc07926509-61-0-3?v=CapitalBio+Corporation
    Average 90 stars, based on 1 article reviews
    smartarray microarray chips capitalbio beijing china - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Runx3 Induces a Cell Shape Change and Suppresses Migration and Metastasis of Melanoma Cells by Altering a Transcriptional Profile"

    Article Title: Runx3 Induces a Cell Shape Change and Suppresses Migration and Metastasis of Melanoma Cells by Altering a Transcriptional Profile

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms22042219

    Microarray analysis uncovered an altered and specific transcriptional profile underlying the cell shape change and the suppression of the metastatic potential by Runx3. ( A ) Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations assigned different repertoires of differentially expressed genes (DEGs) that were regulated by Runx3 in B16-F10 cells and, in the case of B16-F0 cells vs. B16-F10 cells, to the terms relevant to the actin cytoskeleton and adhesion. Each GO/KEGG annotation term is inscribed as a caption. The number of DEGs within a repertoire is described at x axis. The columns for the downregulated and the upregulated DEGs are shown in different colors as explained at the top of the figure., Down/Up by Runx3 indicates the appearance of DEGs in the case of B16-F10/Runx3 cells vs. mock control B16-F10 cells. Down/Up in B16-F0 indicates the appearance of DEGs in the case of B16-F0 cells vs. B16-F10 cells. Down/Up in common indicates the appearance of same DEGs in both cases. ( B ) Runx3 upregulated the expression of extracellular matrix (ECM) genes. The summary table indicates the gene names and their corresponding fold changes. ( C ) Runx3 regulated the expression of a list of DEGs that were inversely associated with an increase in the metastatic potential of B16-F10 cells compared to B16-F0 cells. The heatmap shows the gene names and their fold changes in the cases of B16-F10/Runx3 cells vs. mock control B16-F10 cells and B16-F0 cells vs. B16-F10 cells, respectively.
    Figure Legend Snippet: Microarray analysis uncovered an altered and specific transcriptional profile underlying the cell shape change and the suppression of the metastatic potential by Runx3. ( A ) Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations assigned different repertoires of differentially expressed genes (DEGs) that were regulated by Runx3 in B16-F10 cells and, in the case of B16-F0 cells vs. B16-F10 cells, to the terms relevant to the actin cytoskeleton and adhesion. Each GO/KEGG annotation term is inscribed as a caption. The number of DEGs within a repertoire is described at x axis. The columns for the downregulated and the upregulated DEGs are shown in different colors as explained at the top of the figure., Down/Up by Runx3 indicates the appearance of DEGs in the case of B16-F10/Runx3 cells vs. mock control B16-F10 cells. Down/Up in B16-F0 indicates the appearance of DEGs in the case of B16-F0 cells vs. B16-F10 cells. Down/Up in common indicates the appearance of same DEGs in both cases. ( B ) Runx3 upregulated the expression of extracellular matrix (ECM) genes. The summary table indicates the gene names and their corresponding fold changes. ( C ) Runx3 regulated the expression of a list of DEGs that were inversely associated with an increase in the metastatic potential of B16-F10 cells compared to B16-F0 cells. The heatmap shows the gene names and their fold changes in the cases of B16-F10/Runx3 cells vs. mock control B16-F10 cells and B16-F0 cells vs. B16-F10 cells, respectively.

    Techniques Used: Microarray, Control, Expressing



    Similar Products

    smartarray tm microarray system  (CapitalBio Corporation)
    90
    CapitalBio Corporation smartarray tm microarray system
    Control and normalization sequences for the microRNA <t> microarray. </t>
    Smartarray Tm Microarray System, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/smartarray+tm+microarray+system/pmc06176462-230-12-16?v=CapitalBio+Corporation
    Average 90 stars, based on 1 article reviews
    smartarray tm microarray system - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Control and normalization sequences for the microRNA microarray.

    Journal: Oncology Letters

    Article Title: Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells

    doi: 10.3892/ol.2018.9352

    Figure Lengend Snippet: Control and normalization sequences for the microRNA microarray.

    Article Snippet: These probes were labeled onto a 75×25 mm chemically-modified plate using the SmartArray TM microarray system (CapitalBio Technology, Inc.).

    Techniques: Control, Microarray, Sequencing

    miRNA chip overlay images. (A) Original image of two-channel miRNA microarray; PC-1.0 was labeled with red fluorescent Cy5 dye and PC-1 was labeled with green fluorescent Cy3 dye. (B) Original image of two-channel miRNA microarray; PC-1.0 was labeled with green fluorescent Cy5 dye and PC-1 was labeled with red fluorescent Cy3 dye. (C) Scatter plot of PC-1.0 and PC-1 data. miRNA, microRNA.

    Journal: Oncology Letters

    Article Title: Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells

    doi: 10.3892/ol.2018.9352

    Figure Lengend Snippet: miRNA chip overlay images. (A) Original image of two-channel miRNA microarray; PC-1.0 was labeled with red fluorescent Cy5 dye and PC-1 was labeled with green fluorescent Cy3 dye. (B) Original image of two-channel miRNA microarray; PC-1.0 was labeled with green fluorescent Cy5 dye and PC-1 was labeled with red fluorescent Cy3 dye. (C) Scatter plot of PC-1.0 and PC-1 data. miRNA, microRNA.

    Article Snippet: These probes were labeled onto a 75×25 mm chemically-modified plate using the SmartArray TM microarray system (CapitalBio Technology, Inc.).

    Techniques: Microarray, Labeling

    Reverse transcription-quantitative polymerase chain reaction analysis of highly (PC-1.0) and weakly (PC-1) invasive and metastatic hamster pancreatic cancer cells. A total of 10 miRNAs were selected to verify the reliability of the miRNA microarray data. Of the 10 miRNAs, 6 were upregulated and 4 were downregulated. These results were very similar to the miRNA microarray data, supporting its reliability. Black bar, PC-1.0 cell line. White bar, PC-1 cell line. *P<0.05. miRNA, microRNA.

    Journal: Oncology Letters

    Article Title: Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells

    doi: 10.3892/ol.2018.9352

    Figure Lengend Snippet: Reverse transcription-quantitative polymerase chain reaction analysis of highly (PC-1.0) and weakly (PC-1) invasive and metastatic hamster pancreatic cancer cells. A total of 10 miRNAs were selected to verify the reliability of the miRNA microarray data. Of the 10 miRNAs, 6 were upregulated and 4 were downregulated. These results were very similar to the miRNA microarray data, supporting its reliability. Black bar, PC-1.0 cell line. White bar, PC-1 cell line. *P<0.05. miRNA, microRNA.

    Article Snippet: These probes were labeled onto a 75×25 mm chemically-modified plate using the SmartArray TM microarray system (CapitalBio Technology, Inc.).

    Techniques: Reverse Transcription, Real-time Polymerase Chain Reaction, Microarray